Gland Pharma seeks pitches from investment bankers to go public

Gland Pharma, which is owned 74% by the Chinese major, is seeking a valuation of $3 billion, which is more than twice that of the valuation it was bought in September 2017.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news